Randomized, Double-blind, Vehicle Controlled, Repeat Dose Comparative Study in RA Patients Managed With DMARDs
Status:
Completed
Trial end date:
2021-10-12
Target enrollment:
Participant gender:
Summary
This is a randomized, vehicle controlled, double-blind, repeat dose comparative study in
patients with rheumatoid arthritis (RA) under management with DMARDs and with persistent
disease activity. The goal of this study is to evaluate the safety, tolerability and
pharmacokinetics of 6 weekly repeat doses of ORTD-1.